Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world Effectiveness of Fecal Microbiota Transplantation for First or Second Clostridioides difficile Infection.
Paaske SE, Baumwall SMD, Rubak T, Birn FH, Rågård N, Kelsen J, Hansen MM, Svenningsen L, Krarup AL, Fernis CMC, Neumann A, Lødrup AB, Glerup H, Vinter-Jensen L, Helms M, Erikstrup LT, Grosen AK, Mikkelsen S, Erikstrup C, Dahlerup JF, Hvas CL. Paaske SE, et al. Among authors: glerup h. Clin Gastroenterol Hepatol. 2024 Jun 11:S1542-3565(24)00514-7. doi: 10.1016/j.cgh.2024.05.038. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38871148 Free article.
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators. Wilcox MH, et al. N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615. N Engl J Med. 2017. PMID: 28121498 Free article. Clinical Trial.
Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial.
Münch A, Bohr J, Miehlke S, Benoni C, Olesen M, Öst Å, Strandberg L, Hellström PM, Hertervig E, Armerding P, Stehlik J, Lindberg G, Björk J, Lapidus A, Löfberg R, Bonderup O, Avnström S, Rössle M, Dilger K, Mueller R, Greinwald R, Tysk C, Ström M; BUC-63 investigators. Münch A, et al. Gut. 2016 Jan;65(1):47-56. doi: 10.1136/gutjnl-2014-308363. Epub 2014 Nov 25. Gut. 2016. PMID: 25425655 Free PMC article. Clinical Trial.
Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis.
Miehlke S, Madisch A, Kupcinskas L, Petrauskas D, Böhm G, Marks HJ, Neumeyer M, Nathan T, Fernández-Bañares F, Greinwald R, Mohrbacher R, Vieth M, Bonderup OK; BUC-60/COC Study Group. Miehlke S, et al. Gastroenterology. 2014 May;146(5):1222-30.e1-2. doi: 10.1053/j.gastro.2014.01.019. Epub 2014 Jan 15. Gastroenterology. 2014. PMID: 24440672 Free article. Clinical Trial.
Microfibrillar-associated protein 4 as a predictive biomarker of treatment response in patients with chronic inflammatory diseases initiating biologics: secondary analyses based on the prospective BELIEVE cohort study.
Sofíudóttir BK, Munk HL, Christensen R, Möller S, Overgaard SH, Sorensen GL, Møllegaard KM, Pingel J, Nexøe AB, Glerup H, Guldmann T, Pedersen N, Dahlerup JF, Hvas CL, Andersen KW, Jawhara M, Nielsen OH, Bergenheim FO, Bygum A, Davidsen JR, Sørensen SB, Brodersen JB, Kjeldsen J, Andersen V, Ellingsen T. Sofíudóttir BK, et al. Among authors: glerup h. Rheumatol Int. 2024 Dec;44(12):2935-2947. doi: 10.1007/s00296-024-05744-9. Epub 2024 Oct 28. Rheumatol Int. 2024. PMID: 39465398 Free PMC article.
Impact of gluten intake on clinical outcomes in patients with chronic inflammatory diseases initiating biologics: Secondary analysis of the prospective multicentre BELIEVE cohort study.
Gregersen L, Jessen PD, Lund HW, Overgaard SH, Hikmat Z, Ellingsen T, Kjeldsen J, Pedersen AK, Petersen SR, Jawhara M, Nexøe AB, Bygum A, Hvas CL, Dahlerup JF, Bergenheim FO, Glerup H, Henriksen RH, Guldmann T, Hvid L, Brodersen J, Munk HL, Pedersen N, Saboori S, Nielsen OH, Heitmann BL, Haldorsson TI, Christensen R, Andersen V. Gregersen L, et al. Among authors: glerup h. Scand J Immunol. 2024 Dec;100(6):e13409. doi: 10.1111/sji.13409. Epub 2024 Oct 2. Scand J Immunol. 2024. PMID: 39358910
Effects of smoking on clinical treatment outcomes amongst patients with chronic inflammatory diseases initiating biologics: secondary analyses of the prospective BELIEVE cohort study.
Larsen MGR, Overgaard SH, Petersen SR, Møllegaard KM, Munk HL, Nexøe AB, Glerup H, Guldmann T, Pedersen N, Saboori S, Dahlerup JF, Hvas CL, Andersen KW, Jawhara M, Haagen Nielsen O, Bergenheim FO, Brodersen JB, Bygum A, Ellingsen T, Kjeldsen J, Christensen R, Andersen V. Larsen MGR, et al. Among authors: glerup h. Scand J Immunol. 2024 Sep;100(3):e13395. doi: 10.1111/sji.13395. Epub 2024 Jul 7. Scand J Immunol. 2024. PMID: 38973149
Infant Ustekinumab Clearance, Risk of Infection, and Development After Exposure During Pregnancy.
Julsgaard M, Wieringa JW, Baunwall SMD, Bibby BM, Driessen GJA, Kievit L, Brodersen JB, Poulsen A, Kjeldsen J, Hansen MM, Tang HQ, Balmer CL, Glerup H, Seidelin JB, Haderslev KV, Svenningsen L, Wildt S, Juel MA, Neumann A, Fuglsang J, Jess T, Haase AM, Hvas CL, Kelsen J, Janneke van der Woude C; NEXUS Collaborator Group. Julsgaard M, et al. Among authors: glerup h. Clin Gastroenterol Hepatol. 2025 Jan;23(1):134-143. doi: 10.1016/j.cgh.2024.01.008. Epub 2024 Jan 24. Clin Gastroenterol Hepatol. 2025. PMID: 38278191 Free article.
The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis.
Bossen L, Lau TS, Nielsen MB, Nielsen MC, Andersen AH, Ott P, Becker S, Glerup H, Svenningsen L, Eivindson M, Kornerup L, Kjeldsen NB, Neumann A, Møller HJ, Jepsen P, Grønbæk H. Bossen L, et al. Among authors: glerup h. Hepatol Commun. 2023 Mar 24;7(4):e0068. doi: 10.1097/HC9.0000000000000068. eCollection 2023 Apr 1. Hepatol Commun. 2023. PMID: 36972379 Free PMC article.
Impact of fibre and red/processed meat intake on treatment outcomes among patients with chronic inflammatory diseases initiating biological therapy: A prospective cohort study.
Overgaard SH, Sørensen SB, Munk HL, Nexøe AB, Glerup H, Henriksen RH, Guldmann T, Pedersen N, Saboori S, Hvid L, Dahlerup JF, Hvas CL, Jawhara M, Andersen KW, Pedersen AK, Nielsen OH, Bergenheim F, Brodersen JB, Heitmann BL, Halldorsson TI, Holmskov U, Bygum A, Christensen R, Kjeldsen J, Ellingsen T, Andersen V. Overgaard SH, et al. Among authors: glerup h. Front Nutr. 2022 Oct 13;9:985732. doi: 10.3389/fnut.2022.985732. eCollection 2022. Front Nutr. 2022. PMID: 36313095 Free PMC article.
66 results